Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch maintenance gemcitabine in malignant pleural mesothelioma after pemetrexed-platinum
2012-005834-12Phase 2Completed
- Sponsor
- NVALT
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in pleural mesothelioma comparing Gemcitabine maintenance with Observation / no maintenance (2 arms). Primary endpoint: Progression-free survival. Started May 2013; status: completed.
02
Drugs
gemcitabine
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on 2012-005834-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005834-12.